A critical role for vascular smooth muscle in acute glucocorticoid-lnduced hypertension

Journal of the American Society of Nephrology

Volumn 19, Issue 7, 2008, Pages 1291-1299

  Goodwin, Julie E ^a   Zhang, Junhui ^a   Geller, David S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE; CREATININE; DEXAMETHASONE SODIUM PHOSPHATE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; POTASSIUM; SODIUM; ACTIN BINDING PROTEIN; CRE RECOMBINASE; DEXAMETHASONE; INTEGRASE; MUSCLE PROTEIN; TRANSGELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CIRCADIAN RHYTHM; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EXPERIMENTAL MODEL; FEMALE; HEART RATE; HYPERTENSION; IN VIVO STUDY; KNOCKOUT GENE; MALE; MOUSE; NATRIURESIS; NONHUMAN; POTASSIUM EXCRETION; PRIORITY JOURNAL; SODIUM EXCRETION; URINARY EXCRETION; VASCULAR SMOOTH MUSCLE; ANIMAL; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HEART MUSCLE; METABOLISM; MOUSE MUTANT; PHENOTYPE;

ANIMALS; BLOOD PRESSURE; CIRCADIAN RHYTHM; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; HYPERTENSION; INTEGRASES; MALE; MICE; MICE, KNOCKOUT; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; NATRIURESIS; PHENOTYPE; RECEPTORS, GLUCOCORTICOID;

EID: 48149094765     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2007080911     Document Type: Article

References (38)

1. Mangos GJ, Whitworth JA, Williamson PM, Kelly JJ: Glucocorticoids and the kidney. Nephrology (Carlton) 8: 267-273, 2003
2. Fardet L, Flahault A, Kettaneh A, Tiev KP, Généreau T, Tolédano C, Lebbé C, Cabane J: Corticosteroid-induced clinical adverse events: Frequency, risk factors and patient's opinion. Br J Dermatol 157: 142-148, 2007
3. Ng MK, Celermajer DS: Glucocorticoid treatment and cardiovascular disease. Heart 90: 829-830, 2004
4. Whitworth JA, Coghlan JP, Denton DA, Graham WF, Humphery TJ, Scoggins BA: Comparison of the effects of 'glucocorticoid' and 'mineralocorticoid' infusions on blood pressure in sheep. Clin Exp Hypertens 1: 649-663, 1979
5. Mantero F, Boscaro M: Glucocorticoid-dependent hypertension. J Steroid Biochem Mol Biol 43: 409-413, 1992
6. Provencher PH, Saltis J, Funder JW: Glucocorticoids but not mineralocorticoids modulate endothelin-1 and angiotensin II binding in SHR vascular smooth muscle cells. J Steroid Biochem Mol Biol 52: 219-225, 1995
7. Uno S, Guo DF, Nakajima M, Ohi H, Imada T, Hiramatsu R, Nakakubo H, Nakamura N, Inagami T: Glucocorticoid induction of rat angiotensin II type 1A receptor gene promoter. Biochem Biophys Res Commun 204: 210-215, 1994
8. Yang S, Zhang L: Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol 2: 1-12, 2004
9. Kornel L: The role of vascular steroid receptors in the control of vascular contractility and peripheral vascular resistance. J Steroid Biochem Mol Biol 45: 195-203, 1993
10. Ray KP, Farrow S, Daly M, Talabot F, Searle N: Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids. Biochem J 328: 707-715, 1997
11. Mangos GJ, Walker BR, Kelly JJ, Lawson JA, Webb DJ, Whitworth JA: Cortisol inhibits cholinergic vasodilation in the human forearm. Am J Hypertens 13: 1155-1160, 2000
12. Zhang J, Goodwin J, Geller D: Characterization of a Novel Gain of Function Mutation Glucocorticoid Receptor Knock-in Mouse. Presented at The Endocrine Society Meeting; June 24-27, 2006; Boston, MA
13. Holtwick R, Gotthardt M, Skryabin B, Steinmetz M, Potthast R, Zetsche B, Hammer RE, Herz J, Kuhn M: Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure. Proc Natl Acad Sci U S A 99: 7142-7147, 2002
14. Petrov L, Laurila H, Hayry P, Vamvakopoulos JE: A mouse model of aortic angioplasty for genomic studies of neointimal hyperplasia. J Vasc Res 42: 292-300, 2005
15. Lepore JJ, Cheng L, Min Lu M, Mericko PA, Morrisey EE, Parmacek MS: High-efficiency somatic mutagenesis in smooth muscle cells and cardiac myocytes in SM22alpha-Cre transgenic mice. Genesis 41: 179-184, 2005
16. Zhang JC, Kim S, Helmke BP, Yu WW, Du KL, Lu MM, Strobeck M, Yu Q, Parmacek MS: Analysis of SM22alpha-deficient mice reveals unanticipated insights into smooth muscle cell differentiation and function. Mol Cell Biol 21: 1336-1344, 2001
17. Zelinka T, Strauch B, Pecen L, Widimsky J Jr: Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndrome. J Hum Hypertens 18: 107-111, 2004
18. Zacharieva S, Orbetzova M, Stoynev A, Shigarminova R, Yaneva M, Kalinov K, Nachev E, Elenkova A: Circadian blood pressure profile in patients with Cushing's syndrome before and after treatment. J Endocrinol Invest 27: 924-930, 2004
19. Muller OG, Parnova RG, Centeno G, Rossier BC, Firsov D, Horisberger JD: Mineralocorticoid effects in the kidney: Correlation between alphaENaC, GILZ, and Sgk-1 mRNA expression and urinary excretion of Na+ and K+. J Am Soc Nephrol 14: 1107-1115, 2003
20. Marissal-Arvy N, Mormede P: Excretion of electrolytes in Brown Norway and Fischer 344 rats: Effects of adrenalectomy and of mineralocorticoid and glucocorticoid receptor ligands. Exp Physiol 89: 753-765, 2004
21. Campen TJ, Vaughn DA, Fanestil DD: Mineralo- and glucocorticoid effects on renal excretion of electrolytes. Pflugers Arch 399: 93-101, 1983
22. Frey FJ, Odermatt A, Frey BM: Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension. Curr Opin Nephrol Hypertens 13:451-458, 2004
23. Whitworth JA, Brown MA, Kelly JJ, Williamson PM: Mechanisms of cortisol-induced hypertension in humans. Steroids 60: 76-80, 1995
24. Wallwork CJ, Parks DA, Schmid-Schonbein GW: Xanthine oxidase activity in the dexamethasone-induced hypertensive rat. Microvasc Res 66: 30-37, 2003
25. Montrella-Waybill M, Clore JN, Schoolwerth AC, Watlington CO: Evidence that high dose cortisol-induced Na+ retention in man is not mediated by the mineralocorticoid receptor. J Clin Endocrinol Metab 72: 1060-1066, 1991
26. Williamson PM, Kelly JJ, Whitworth JA: Dose-response relationships and mineralocorticoid activity in cortisol-induced hypertension in humans. J Hypertens Suppl 14: S37-S41, 1996
27. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM: Cloning of human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor. Science 237: 268-275, 1987
28. De Wachter E, Malfroot A, De Schutter I, Vanbesien J, De Schepper J: Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450. J Cyst Fibros 2: 72-75, 2003
29. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, Kanaide H, Takeshita A: Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 106: 1521-1530, 2000
30. Borges AA, Gomes OM: Effects of midazolam on the contraction and relaxation of segments of thoracic aorta stripped of endothelium and stimulated by adrenaline: Experimental study in rabbits. Mol Cell Biochem 246: 13-17, 2003
31. Bal MP, de Vries WB, van der Leij FR, van Oosterhout MF, Berger RM, Baan J, van der Wall EE, van Bel F, Steendijk P: Neonatal glucocorticosteroid treatment causes systolic dysfunction and compensatory dilation in early life: Studies in 4-week-old prepubertal rats. Pediatr Res 58: 46-52, 2005
32. Dodic M, McAlinden AT, Jefferies AJ, Wintour EM, Cock ML, May CN, Evans RG, Moritz KM: Differential effects of prenatal exposure to dexamethasone or cortisol on circulatory control mechanisms mediated by angiotensin II in the central nervous system of adult sheep. J Physiol 571: 651-660, 2006
33. Chen YC, Cadnapaphornchai MA, Summer SN, Falk S, Li C, Wang W, Schrier RW: Molecular mechanisms of impaired urinary concentrating ability in glucocorticoid-deficient rats. J Am Soc Nephrol 16: 2864-2871, 2005
34. Haigh RM, Jones CT, Milligan G: Glucocorticoids regulate the amount of G proteins in rat aorta. J Mol Endocrinol 5: 185-188, 1990
35. Haigh RM, Jones CT: Effect of glucocorticoids on alpha 1-adrenergic receptor binding in rat vascular smooth muscle. J Mol Endocrinol 5: 41-48, 1990
36. Patzak A, Bontscho J, Lai E, Kupsch E, Skalweit A, Richter CM, Zimmermann M, Thöne-Reineke C, Joehren O, Godes M, Steege A, Hocher B: Angiotensin II sensitivity of afferent glomerular arterioles in endothelin-1 transgenic mice. Nephrol Dial Transplant 20: 2681-2689, 2005
37. Wintermantel TM, Berger S, Greiner EF, Schutz G: Evaluation of steroid receptor function by gene targeting in mice. J Steroid Biochem Mol Biol 93: 107-112, 2005
38. Plehm R, Barbosa ME, Bader M: Animal models for hypertension/blood pressure recording. Methods Mol Med 129: 115-126, 2006